Primer: Cargo Therapeutics (CRGX US) - Aug 2026
Cargo Therapeutics is a clinical-stage biotechnology company that was focused on developing next-generation CAR T-cell therapies for cancer....
101 Views
CARGO Therapeutics IPO Preview: A Promising Pipeline of Next-Gen CAR T-Cell Therapies
A VC-backed biotech firm CARGO Therapeutics filed for an IPO. The company develops CAR T-cell products for adult patients with relapsed or...
917 Views
No more insights